10.7 million people developed tuberculosis worldwide | WHO Global Tuberculosis Report 2025

Tuberculosis is still one of the infectious diseases that claims many lives around the world. In November 2025, the World Health Organization (WHO) published the Global Tuberculosis Report 2025. Here, we look at the global situation in 2024 through the numbers.

10.7 million people developed TB; 1.2 million died

According to WHO estimates, 10.7 million people worldwide developed tuberculosis in 2024. The breakdown is 5.8 million men, 3.7 million women, and 1.2 million children. The number of people who died from tuberculosis is estimated at 1.2 million.

A decline for the first time in 3 years

From 2023 to 2024, the incidence rate per population fell by 2%, and the number of deaths fell by 3%. This was the first indication of a decline in new cases in 3 years. Looking at changes since 2015 by region, the African Region saw a 28% decline in incidence and a 46% decline in deaths, while the European Region saw a 39% decline in incidence and a 49% decline in deaths.

WHO Global Tuberculosis Report 2025 (2024 estimates)
・People who developed TB: 10.7 million (5.8 million men / 3.7 million women / 1.2 million children)
・People who died: 1.2 million
・Year on year: incidence rate -2%, deaths -3%

The challenge of insufficient funding

At the same time, WHO warns that a decline in international funding could put past achievements at risk of being reversed. Drug resistance, another global challenge, was covered in WHO’s report on drug resistance. In Japan as well, tuberculosis is not a disease of the past, and new patients are reported every year. If you are concerned about a lingering cough or similar symptoms, please consult a medical institution as soon as possible.

Reference: World Health Organization (WHO), Global Tuberculosis Report 2025

※This article introduces statistics and system information published by public institutions and is not intended to diagnose, treat, or prevent any specific disease. If you have health concerns, please consult a medical institution.

—The Value Village Editorial Team